Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Genzyme has agreed to sell its Genzyme Genetics testing services business, which had revenues of $370 million in 2009, to Laboratory Corporation of America for $925 million. The sale is part of a five-year plan that Genzyme announced in May to find alternatives for three noncore units. It is trying to strengthen its business in the face of near-devastating manufacturing problems and after rejecting a takeover offer from Sanofi-Aventis. In addition to the sale, Genzyme will also cut 1,000 jobs over 15 months to reduce operating costs.
This article has been sent to the following recipient: